We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+2.22%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$2.62B
AUM Growth
-$406M
Cap. Flow
-$413M
Cap. Flow %
-15.8%
Top 10 Hldgs %
24.39%
Holding
266
New
55
Increased
52
Reduced
73
Closed
75

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.14%
2 Financials 18.1%
3 Healthcare 17.15%
4 Communication Services 11.23%
5 Technology 10.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RH icon
76
RH
RH
$2.36B
$12.8M 0.49%
131,233
-5,800
-4% -$535K
HOLX
77
DELISTED
Hologic
HOLX
$12.8M 0.49%
335,095
-344,900
-51% -$12.1M
NILE
78
DELISTED
Blue Nile, Inc.
NILE
$12.4M 0.47%
408,592
+62,900
+18% +$1.8M
DVAX
79
DELISTED
Dynavax Technologies
DVAX
$12.3M 0.47%
523,908
-292,400
-36% -$6.37M
LGF
80
DELISTED
Lions Gate Entertainment
LGF
$12.1M 0.46%
326,021
+76,700
+31% +$2.56M
LADR
81
Ladder Capital
LADR
$1.21B
$11.7M 0.45%
840,552
+99,820
+13% +$1.43M
HCA icon
82
HCA Healthcare
HCA
$91.8B
$11.2M 0.43%
123,299
-265,400
-68% -$21.3M
ALXN
83
DELISTED
Alexion Pharmaceuticals
ALXN
$10.6M 0.4%
+58,580
New +$10.1M
MTW icon
84
Manitowoc
MTW
$741M
$10.4M 0.4%
+584,547
New +$10.7M
MSFT icon
85
Microsoft
MSFT
$3.69T
$10.2M 0.39%
231,853
+136,600
+143% +$6.23M
FWP
86
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$10.1M 0.39%
+37,886
New +$9.07M
WELL icon
87
Welltower
WELL
$168B
$9.67M 0.37%
+147,300
New +$10.6M
ANDV
88
DELISTED
Andeavor
ANDV
$9.57M 0.37%
113,326
-40,200
-26% -$3.49M
VLO icon
89
Valero Energy
VLO
$114B
$8.94M 0.34%
142,800
-51,700
-27% -$3.05M
EFII
90
DELISTED
Electronics for Imaging
EFII
$8.89M 0.34%
204,400
-6,400
-3% -$276K
LBRDA
91
DELISTED
Liberty Broadband Class A
LBRDA
$8.32M 0.32%
163,218
-2,900
-2% -$154K
PHM icon
92
Pultegroup
PHM
$22.8B
$7.98M 0.31%
396,251
-615,774
-61% -$12.5M
SWKS icon
93
Skyworks Solutions
SWKS
$13.5B
$7.63M 0.29%
73,325
-3,175
-4% -$321K
CORV
94
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$7.41M 0.28%
787,583
+190,400
+32% +$1.77M
ROL icon
95
Rollins
ROL
$16.2B
$7.35M 0.28%
579,753
-24,525
-4% -$277K
UAM
96
DELISTED
Universal American Corp
UAM
$7.3M 0.28%
721,673
-1,000
-0.1% -$10.4K
UUP icon
97
Invesco DB US Dollar Index Bullish Fund
UUP
$322M
$7.1M 0.27%
283,604
+210,904
+290% +$5.32M
ITCI
98
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$7.09M 0.27%
221,800
-3,200
-1% -$81.1K
CVRS
99
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$7.04M 0.27%
+2,005,200
New +$8.55M
DERM
100
DELISTED
Dermira, Inc.
DERM
$6.71M 0.26%
382,100
-16,500
-4% -$254K

Similar funds

Clough Capital Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Clough Capital Partners held 266 positions worth $2.62B, down 13% from $3.02B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Clough Capital Partners withdrew a net $413M in Q2 2015, closing 75 positions and reducing 73 holdings. Its most notable exit was Western Union, an estimated $40.2M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Clough Capital Partners opened a new position in Kansas City Southern worth $52.7M.

  • Clough Capital Partners's largest Q2 2015 buy was Kansas City Southern: 578,370 shares worth $52.7M.
  • Clough Capital Partners added most to Calpine Corporation in Q2 2015, an estimated $28.7M increase.
  • Clough Capital Partners's biggest Q2 2015 reduction was iShares China Large-Cap ETF, cutting an estimated $52.3M.
  • Clough Capital Partners fully exited Western Union in Q2 2015, selling an estimated $40.2M.
  • Clough Capital Partners's ten largest holdings make up 24% of its $2.62B portfolio in Q2 2015.
  • Clough Capital Partners opened 55 new positions and closed 75 in Q2 2015.
  • Clough Capital Partners's portfolio value fell 13% quarter-over-quarter to $2.62B.

Based on Clough Capital Partners's 13F filing for Q2 2015, filed 14 Aug 2015.